Nordøy T - Search Results

1

Prevalence of pain in hospitalised cancer patients in Norway: a national survey.

Holtan A, Aass N, Nordøy T, Haugen DF, Kaasa S, Mohr W, Kongsgaard UE. Holtan A, et al. Among authors: nordoy t. Palliat Med. 2007 Jan;21(1):7-13. doi: 10.1177/0269216306073127. Palliat Med. 2007. PMID: 17169954

2

[Tumour-modifying therapy].

Aass N, Bjordal K, Tveit KM, Nordøy T. Aass N, et al. Among authors: nordoy t. Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):628-32. Tidsskr Nor Laegeforen. 2006. PMID: 16505877 Free article. Review. Norwegian.

3

Palliative Treatment of Cancer-Related Pain [Internet].

Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A. Kongsgaard U, et al. Among authors: nordoy t. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005. PMID: 29320015 Free Books & Documents. Review.

4

High level of fatigue in lymphoma patients treated with high dose therapy.

Knobel H, Loge JH, Nordøy T, Kolstad AL, Espevik T, Kvaløy S, Kaasa S. Knobel H, et al. Among authors: nordoy t. J Pain Symptom Manage. 2000 Jun;19(6):446-56. doi: 10.1016/s0885-3924(00)00144-5. J Pain Symptom Manage. 2000. PMID: 10908825 Free article.

5

Centralized inpatient palliative care units in remote areas: an obstacle to future home care?

Donnem T, Nordoy T, Ervik B, Jordhoy MS. Donnem T, et al. Among authors: nordoy t. Palliat Med. 2006 Mar;20(2):116-7. Palliat Med. 2006. PMID: 16613408 No abstract available.

6

Persistent changes in the immune system 4-10 years after ABMT.

Nordøy T, Kolstad A, Endresen P, Holte H, Kvaløy S, Kvalheim G, Husebekk A. Nordøy T, et al. Bone Marrow Transplant. 1999 Oct;24(8):873-8. doi: 10.1038/sj.bmt.1702006. Bone Marrow Transplant. 1999. PMID: 10516699

7

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Nordøy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB, Kristoffersen AC, Holte H, Kvaløy S, Kolstad A. Nordøy T, et al. Bone Marrow Transplant. 2001 Oct;28(7):681-7. doi: 10.1038/sj.bmt.1703228. Bone Marrow Transplant. 2001. PMID: 11704791

8

Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens.

Nordøy T, Kolstad A, Tuck MK, Aaberge IS, Husebekk A, Kaminski MS. Nordøy T, et al. Clin Immunol. 2001 Jul;100(1):40-8. doi: 10.1006/clim.2001.5050. Clin Immunol. 2001. PMID: 11414744

9

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae.

Nordøy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, Kolstad A. Nordøy T, et al. Med Oncol. 2002;19(2):71-8. doi: 10.1385/MO:19:2:71. Med Oncol. 2002. PMID: 12180483

10

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment.

Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A. Yri OE, et al. Among authors: nordoy t. Blood. 2011 Dec 22;118(26):6769-71. doi: 10.1182/blood-2011-08-372649. Epub 2011 Nov 4. Blood. 2011. PMID: 22058114 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters